$6.30
−5.12%Oct 13, 2026, 12:00 UTC
NutriBand Inc. received $1,753,274.53 in proceeds after 272,671 warrants were exercised at $6.43 each.
Source:Oct 8, 2026, 11:00 UTC
NutriBand Inc. filed a new non-provisional patent application to strengthen intellectual property protection for its AVERSA™ transdermal abuse-deterrent technology.
Source:Sep 29, 2026, 13:25 UTC
Nutriband Inc. announced that its CEO Gareth Sheridan was featured in a new documentary by filmmaker Nick Shirley examining the opioid crisis in the United States.
Source:Sep 22, 2026, 12:00 UTC
Nutriband Inc. confirmed that its outstanding NASDAQ-listed warrants will expire on September 30, 2026 at 5PM ET as scheduled, without extension or repricing.
Source: